Bisphosphonates in the treatment of HIV-related osteoporosis

Endocrine. 2015 Mar;48(2):358-9. doi: 10.1007/s12020-014-0488-3. Epub 2014 Nov 26.

Authors

Fabio Vescini¹, Franco Grimaldi

Affiliation

¹ Endocrinology and Metabolism Unit, University-Hospital S. Maria della Misericordia, Udine, Italy, vescini.fabio@aoud.sanita.fvg.it.

PMID: 25424437
DOI: 10.1007/s12020-014-0488-3

No abstract available

Publication types

Editorial

MeSH terms

Adult
Bone Density Conservation Agents / therapeutic use*
Diphosphonates / therapeutic use*
Female
HIV Infections / complications*
Humans
Male
Middle Aged
Osteoporosis / drug therapy*
Osteoporosis / etiology

Substances

Bone Density Conservation Agents
Diphosphonates